Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SGLT2i”

114 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 114 results

Not applicableUnknownNCT04853615
What this trial is testing

SGLT2 Inhibitors Prophylaxis Against Post-contrast Acute Kidney Injury in Diabetic Kidney Disease?

Who this might be right for
SGLT2i Kideny Protection Against Contrast in Diabetic Kidney
Fayoum University 800
Testing effectiveness (Phase 2)Study completedNCT06150924
What this trial is testing

Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria

Who this might be right for
Chronic Kidney Disease
Mineralys Therapeutics Inc. 60
Post-approval studies (Phase 4)Looking for participantsNCT07228195
What this trial is testing

SGLT2i Therapy in Islet Transplantation (SIT)

Who this might be right for
Partial Islet FunctionTPIATDiabetes
University of Minnesota 40
Post-approval studies (Phase 4)Study completedNCT05677334
What this trial is testing

Combination of Henagliflozin and Continuous Subcutaneous Insulin Infusion in T2DM

Who this might be right for
Type2diabetes
First Affiliated Hospital of Guangxi Medical University 210
Testing effectiveness (Phase 2)Looking for participantsNCT05138575
What this trial is testing

SGLT2i and KNO3 in HFpEF - The SAK HFpEF Trial

Who this might be right for
Heart Failure With Preserved Ejection Fraction
University of Pennsylvania 53
Post-approval studies (Phase 4)Study completedNCT05989503
What this trial is testing

Initiation of ARNi and SGLT2i in Patients With HFrEF

Who this might be right for
Heart Failure With Reduced Ejection Fraction
Universidade do Porto 62
Very early researchLooking for participantsNCT07055282
What this trial is testing

SGLT2i in Kidney Stones

Who this might be right for
Kidney Stones
University of Chicago 32
Post-approval studies (Phase 4)Study completedNCT05541484
What this trial is testing

Ketone Monitoring in T1D: Effect of SGLT2i During Usual Care and With Insulin Deficiency

Who this might be right for
Diabetes Mellitus, Type 1
Washington University School of Medicine 21
Post-approval studies (Phase 4)Looking for participantsNCT06674109
What this trial is testing

SAVE-Care (Sodium Glucose Cotransporter-2 Inhibitors [SGLT2i] As Novel Gout Care) Trial

Who this might be right for
Gout and Hyperuricemia
Massachusetts General Hospital 60
Post-approval studies (Phase 4)Study completedNCT06171802
What this trial is testing

EMPagliflozin After Aortic Valve Replacement

Who this might be right for
Aortic Valve Stenosis
Rigshospitalet, Denmark 206
Post-approval studies (Phase 4)Study completedNCT04700839
What this trial is testing

SGLT2 Inhibitors in Patients With PCOS

Who this might be right for
Polycystic Ovary Syndrome
Shanghai 10th People's Hospital 68
Not applicableNot Yet RecruitingNCT07272057
What this trial is testing

SGLT2 Inhibitors and Survival in Lung Cancer Patients With Diabetes

Who this might be right for
Lung Cancer
Shanghai Chest Hospital 200
Large-scale testing (Phase 3)Active Not RecruitingNCT07586371
What this trial is testing

Proteinuria in Normotensive Diabetic Patients: ARBs Alone or in Combination of SGLT2i

Who this might be right for
ProteinuriaDiabetes (DM)
Dr Mudassar Saeed Pansota 60
Large-scale testing (Phase 3)Study completedNCT04400760
What this trial is testing

The Effect of Dapagliflozin on Platelet Function testinG Profiles in Diabetic PatiEnts.

Who this might be right for
Platelet Dysfunction
The University of The West Indies 40
Not applicableStudy completedNCT06708091
What this trial is testing

Real-world Clinical Effectiveness and Patient Insight Associated With Adding Sodium Glucose Co-transporter 2 Inhibitor to Gliclazide Modified Release

Who this might be right for
Type 2 Diabetes
Servier Affaires Médicales 537
Not applicableNot Yet RecruitingNCT07723820
What this trial is testing

Glycemic Velocity and Early Retinal Microvascular Change With GLP-1RA Versus SGLT2i Initiation in Type 2 Diabetes (GLIDE)

Who this might be right for
Type 2 Diabetes MellitusDiabetic Retinopathy (DR)
Thammasat University Hospital 126
Testing effectiveness (Phase 2)Looking for participantsNCT07482020
What this trial is testing

SGLT2i Improve Left Atrial Function in Patients With Paroxysmal Atrial Fibrillation, Hypertension and Abnormal Glucose Metabolism

Who this might be right for
Atrial Fibrillation (AF)Hypertension
Huashan Hospital 66
Post-approval studies (Phase 4)Study completedNCT03646292
What this trial is testing

Antidiabetic Drugs for Steatotic Liver Disease

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseType 2 DiabetesDigestive System Disease+11 more
Yonsei University 51
Testing effectiveness (Phase 2)Study completedNCT05834738
What this trial is testing

Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy

Who this might be right for
IgA NephropathyImmunoglobulin A Nephropathy
Novartis Pharmaceuticals 54
Testing effectiveness (Phase 2)UnknownNCT06731231
What this trial is testing

SGLT2i in Diabetic Patients with Renal Transplantation

Who this might be right for
Post-transplant Diabetes Mellitus
Ain Shams University 72
Next Page